IMBRUVICA 140 mg film-coated tablets clinical trials

Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)

This study is looking at a medicine called ibrutinib for children and young people with chronic Graft Versus Host Disease (cGVHD). It aims to find the right dose and check how safe and effective it is for those aged 1 to 22 years.